Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Protalix BioTherapeutics, Inc. | Sr. VP and CFO | Common Stock | 661K | $932K | $1.41 | Sep 23, 2024 | By Trust |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PLX | Protalix BioTherapeutics, Inc. | Sep 23, 2024 | 1 | $0 | 4/A | Nov 5, 2024 | Sr. VP and CFO |
PLX | Protalix BioTherapeutics, Inc. | Aug 15, 2023 | 1 | $0 | 4 | Aug 17, 2023 | Sr. VP and CFO |
PLX | Protalix BioTherapeutics, Inc. | Sep 7, 2022 | 1 | $0 | 4 | Sep 9, 2022 | Sr. VP and CFO |
PLX | Protalix BioTherapeutics, Inc. | Feb 25, 2022 | 1 | $0 | 4 | Feb 28, 2022 | Sr. VP and CFO |